← All organizations

Rigontec GMBH

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 25, 2017

Acquired by Merck on Sep 6, 2017

Timeline

2010s

Jan 1, 2014
Rigontec GMBH— Founded
Sep 6, 2017
Merck— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

mk-4621

Indications

Studied for

Neoplasms

Recent trials (2)

NCT03065023Study directorPhase 1/Phase 2Apr 25, 2017
NCT03065023Lead sponsorPhase 1/Phase 2Apr 25, 2017

Details

Founded: Martinsried, DE Jan 1, 2014
Last known activity: Apr 25, 2017